These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8668079)

  • 1. Effective control of bone pain by octreotide in a patient with metastatic gastrinoma.
    Burgess JR; Shepherd JJ; Murton FJ; Parameswaran V; Greenaway TM
    Med J Aust; 1996 Jun; 164(12):725-7. PubMed ID: 8668079
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide in control of multiple liver metastases from gastrinoma.
    Saijo F; Naito H; Funayama Y; Fukushima K; Shibata C; Hashimoto A; Kitayama T; Nagao M; Matsuno S; Sasaki I
    J Gastroenterol; 2003; 38(9):905-8. PubMed ID: 14564638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new concept of therapeutic strategy for neuroendocrine tumors: important information from a case report of gastrinoma.
    Igarashi H; Ito T; Takayanagi R
    Intern Med; 2010; 49(17):1839-40. PubMed ID: 20823641
    [No Abstract]   [Full Text] [Related]  

  • 5. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
    Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
    World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Asymptomatic multinodular liver disease].
    Cadiot G
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B154-8. PubMed ID: 12843952
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surgical and drug therapy of metastatic gastrinoma. Successful palliation over the course of 2 1/2 years].
    Miller W; Butters M; Bittner R
    Chirurg; 1995 May; 66(5):541-4. PubMed ID: 7541744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
    Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
    Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
    Dtsch Med Wochenschr; 2004 Mar; 129(13):689-92. PubMed ID: 15026965
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancreatic endocrine tumors.
    Chun J; Doherty GM
    Curr Opin Oncol; 2001 Jan; 13(1):52-6. PubMed ID: 11148686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone metastasis from gastrinoma without hepatic involvement. Utility of the scintigraphy with 111 In-pentetreotide].
    Cortés M; Mora J; Benítez A; González MJ; Castell M; Martín-Comín J
    Rev Esp Med Nucl; 2001 Feb; 20(1):23-6. PubMed ID: 11181326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1). Implications for an integrated model of MEN-1 tumorigenesis.
    Burgess JR; Greenaway TM; Parameswaran V; Shepherd JJ
    Cancer; 1999 Nov; 86(10):2154-9. PubMed ID: 10570446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotide.
    van de Loosdrecht AA; van Bodegraven AA; Sepers JM; Sindram JW
    Neth J Med; 1998 Sep; 53(3):118-23. PubMed ID: 9803143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term suppressive effect of octreotide on progression of metastatic gastrinoma with multiple endocrine neoplasia type 1: seven-year follow up.
    Yamaguchi M; Yamada Y; Hosokawa Y; Iwamoto R; Tamba S; Ihara A; Yamamoto K; Hoshida Y; Matsuzawa Y
    Intern Med; 2010; 49(15):1557-63. PubMed ID: 20686291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of multiple hepatic metastases of gastrinoma not apparent on CT by In-111 octerotide scintigraphy.
    McInerney GF; Carmalt H; MaGee M; Allman K; van der Wall H
    Clin Nucl Med; 1996 Sep; 21(9):730-1. PubMed ID: 8879876
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of metastatic gastrinomas in the liver visualized by 111In-DTPA-D-Phe-octreotide (111In-pentetreotide)].
    Tani A; Nakabeppu Y; Tsuchimochi S; Nakajo M; Yoshinaga T; Kiku T
    Kaku Igaku; 1996 May; 33(5):545-9. PubMed ID: 8699623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.
    Ricci S; Antonuzzo A; Galli L; Ferdeghini M; Bodei L; Orlandini C; Conte PF
    Ann Oncol; 2000 Sep; 11(9):1127-30. PubMed ID: 11061606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide as a rapid and effective painkiller for metastatic carcinoid tumor.
    Katai M; Sakurai A; Inaba H; Ikeo Y; Yamauchi K; Hashizume K
    Endocr J; 2005 Apr; 52(2):277-80. PubMed ID: 15863961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire.
    Pistevou-Gombaki K; Eleftheriadis N; Plataniotis GA; Sofroniadis I; Kouloulias VE
    Palliat Med; 2003 Apr; 17(3):257-62. PubMed ID: 12725479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone metastases in epidural invasion of gastrinoma].
    Durieux S; Lioté F; Timsit MA; Duet M; Valleur P; Lemaire V; Dryll A
    Rev Rhum Ed Fr; 1994 Jun; 61(6):453-5. PubMed ID: 7833871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.